Understanding HPV vaccine decisions in teenage girls
Part of Infections, Women’s health & pregnancy clinical trials.
This study helps researchers understand why some teenage girls and their families choose or don't choose HPV vaccination, and tests a new way to support families in making this decision together. The HPV vaccine helps prevent certain cancers later in life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a girl aged 9–17 years old
- You have never received any HPV vaccine shots
- You are visiting a doctor's office, health clinic, or vaccination clinic
- At least one parent or legal guardian can participate with you in the study
- You plan to stay in the same area for the next 12 months so researchers can follow up with you
- Your parent or guardian agrees in writing, and you agree to join (based on local rules)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a game to teach children ages 11-14 about the HPV vaccine and why it's important. It's for kids who haven't gotten the vaccine yet and their parent or guardian.
This study tests how well the HPV vaccine works in women and teens. It's for those who are willing to get an HPV test and haven't already had all 3 doses of the vaccine.
This study tests digital messages (like texts or videos) to help parents in Nigeria decide about the HPV vaccine for their daughters. The vaccine protects against certain cancers, and the goal is to see what messages work best.
This trial asks mothers or female guardians who have some concerns about the HPV vaccine to share their stories. The goal is to create messages that help other parents make informed decisions about the vaccine for their children.
This study checks how well two types of domestic HPV vaccines and one imported HPV vaccine boost your immune system. It is for girls aged 13-14 who have already finished their HPV vaccine shots about a month ago.
This study tests whether real-time reminders and guidance help families stay on track with the HPV vaccine for children who are 11–12 years old. It’s a “feasibility” study, meaning it focuses on whether the approach is practical and acceptable.
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.